Internal Server Error

About Green Park & Golf Ventures

Green Park & Golf Ventures is a venture capital firm founded in 2011. It is primarily based out of Dallas, United States. As of Jun 2025, Green Park & Golf Ventures is an active investor, having invested in 81 companies, with 1 new investment in the last 12 months. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Series A round of Vellum Health Overall, Green Park & Golf Ventures portfolio has seen 5 IPOs and 13 acquisitions including key companies like Savara Pharma, Lantern Pharma and Salarius Pharma. A lot of funds co-invest with Green Park & Golf Ventures, with names like North Texas Angel Network sharing a substantial percentage of its portfolio. Green Park & Golf Ventures has team of 7 people including 4 partners.
Key Metrics
Portfolio Locations
Rounds of Entry
Seed, Series A & 3 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months

Green Park & Golf Ventures' List of Top Investments

Green Park & Golf Ventures has a portfolio of 81 companies. Their most notable investments are in PuraCath Medical and Nasseo.Their portfolio spans across United States, Germany and United Kingdom. They have invested in Life Sciences, Enterprise Applications, HealthTech and 21 other sectors, across stages such as Seed, Series A  and 3 more. Here is the list of top investments by Green Park & Golf Ventures:
Provider of a suite primary care platform for providers. The platform allows patients to connect with healthcare experts through video calls/text messaging. Users can seek medical guidance and receive personalized treatment through online consultations with doctors. Also, it provides home-based diagnostic/lab test solutions for patients. It allows customers to know the specific genes responsible for causing disease. Also, it provides services to healthcare providers, organizations, and payers.

Key facts about Recuro Health

Developer of therapeutics for rare respiratory diseases. The company’s lead product is molgramostim nebulizer solution, which is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) for autoimmune pulmonary alveolar proteinosis (aPAP).

Key facts about Savara Pharma

Provider of a single-cell multi-omics platform for genotypic and phenotypic analysis. The company's proprietary Tapestri platform enables the simultaneous detection of analytes, including SNVs, CNVs, and proteins for the precise treatment of cancer. Also, it offers DNA & protein panels, and Pharma Assay Development (PAD) Services.

Key facts about Mission Bio

  • Founded Year: 2014
  • Location: San Francisco (United States)
  • Stage: Series C
  • Total Funding till date: $120M
  • Employee Count: 88 as on Apr 30, 2026
  • Investors: Cota Capital, LabCorp and 28 Others
  • Latest Funding Round: Series C, Aug 05, 2025, $*****
  • Highlight: Editors' Pick
Developer of neuromodulation therapy for neurological conditions. The company uses proprietary technology and product- microtransponder's product is the Vivistim Paired VNS System, for helping stroke survivors regain upper limb motor function after their stroke.

Key facts about MicroTransponder

5. Alto

App-based for booking ride hailing services. Users can book rides through the platform by providing location, destination, user details, payment details, preferred dates, and more. The app is available for both Android and iOS devices.

Key facts about Alto

Green Park & Golf Ventures' Investments by Stage

Green Park & Golf Ventures has made 15 investments in Seed stage with an average round size of $1.46M, 11 investments in Series A stage with an average round size of $4.61M, 9 investments in Series B stage with an average round size of $15.9M, 2 investments in Series C stage with an average round size of $3.39M and 1 investment in Conventional Debt stage.
Here are Green Park & Golf Ventures' investments by stage:
Stage of entry
No. of Investments
Seed
15
Series A
11
Series B
9
Series C
2
Conventional Debt
1
Breakdown of Green Park & Golf Ventures' investments by stage of entrySeed (15)Series A (11)
Note: We have considered here, only first round of investments

Green Park & Golf Ventures' Investments by Sector

Green Park & Golf Ventures has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, HealthTech, Consumer and High Tech. Notably, it has invested in 72 Tech companies, 68 Enterprise (B2B) companies, 40 Software companies and at least 16 companies focusing on Tech hardware.
Here are Green Park & Golf Ventures' investments by sector:
Sector
No. of Investments
Life Sciences
19
Enterprise Applications
15
HealthTech
10
Consumer
6
High Tech
6
Others
30
Breakdown of Green Park & Golf Ventures' investments by sectorsLife Sciences (19)Enterprise Applic... (15)
Note: We have considered here, only first round of investments

Green Park & Golf Ventures' Investments by Geography

Green Park & Golf Ventures has made most investments in United States (36), followed by Germany where it has made 1 investment.
Here are Green Park & Golf Ventures' investments by geography:
Country
No. of Investments
United States
36
Germany
1
United Kingdom
1
Breakdown of Green Park & Golf Ventures' investments by countriesUnited States (36)Germany (1)
Note: We have considered here, only first round of investments

Green Park & Golf Ventures' recent investments

Green Park & Golf Ventures has not made any investment in 2026 so far.
Here are the most recent investments by Green Park & Golf Ventures:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Jun 26, 2025
United States
Series A
5765
Apr 22, 2025
United States
Seed
7199
  [+2]
Mar 05, 2025
United States
Series F
9107
  [+6]
Feb 03, 2025
United States
Series A
5385
  [+4]
Feb 27, 2024
United States
Seed
1121

IPOs and Publicly Listed companies in Green Park & Golf Ventures' Portfolio

5 of Green Park & Golf Ventures' portfolio companies have become public. Lantern Pharma got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jun 2020 at marketcap of $93.3M and Atreca got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $455M.
Here are Green Park & Golf Ventures' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Jun 11, 2020
Feb 26, 2015
Seed
1911
Jun 20, 2019
-
-
4878
Jul 27, 2018
-
-
3087
Apr 27, 2017
-
-
5078
-
-
-
7803

Acquired companies in Green Park & Golf Ventures' Portfolio

13 companies from Green Park & Golf Ventures' portfolio have been acquired. The most recent acquisition was Semler Scientific in Jan 2026 by Strive for $*****.
Here are Green Park & Golf Ventures' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Jan 16, 2026
-
-
6173
Aug 22, 2023
Nov 30, 2018
Series A
1386
Jul 29, 2022
Mar 24, 2016
Series B
1019
Dec 20, 2021
Jul 2013
Seed
1026
Jun 26, 2021
-
-
4130

Team profile of Green Park & Golf Ventures

Green Park & Golf Ventures has a team of 7 members including 4 Partners and 1 Principal located in United States. Green Park & Golf Ventures' team does not sit on the board of any company as of now.
Here is a list of all team members in Green Park & Golf Ventures:
Name
Designation
Location
Board Memberships
Contact Details
Partner
Dallas
-
Partner
Dallas
-
Partner
Austin
-
-
Partner
Dallas
-
Principal
Houston
-

Co-investors of Green Park & Golf Ventures

Over the past 14 years, 157 investors have co-invested in Green Park & Golf Ventures's portfolio companies. This includes funds and angels.

  • Invested before Green Park & Golf VenturesHHS, Health Wildcatters and 46 others have invested in rounds before Green Park & Golf Ventures. There are 8 companies where HHS has invested before Green Park & Golf Ventures and 4 companies where Health Wildcatters has invested before Green Park & Golf Ventures.
  • Top Co-investors of Green Park & Golf Ventures63 investors entered a company along with Green Park & Golf Ventures. These include investors like North Texas Angel Network (3 companies).
  • Invested after Green Park & Golf VenturesA total of 46 investors have invested in Green Park & Golf Ventures's portfolio after their investments. Top Investors include Perot Jain (2 companies), NIH (2 companies) and Flippen Group (1 company).

Recent News related to Green Park & Golf Ventures

View all news related to Green Park & Golf Ventures

FAQs about Green Park & Golf Ventures

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford